Cutaneous Manifestations of Primary Sjögren's Syndrome: A Reflection of Vasculitis and Association with Anti-RO(SSA) Antibodies  by Alexander, Elaine L. & Provost, Thomas T.
386 ALEXANDER AND PROVOST 
The reason for certain str a ins of mice responding less well to 
topical application of TNCB to t h e tail is unclear. Toews et a! 
have quan titated the number of ATPase-posit ive cells on t h e 
tail epidermis of BALB/c nu/ nu a nd C57Bl/6 mice a nd found 
fewer ATPase-positive cells in t he C57Bl/6 [9]. W e, however, 
did not find any significan t strain differences in t h e density of 
ATPase-positive cells in tail skin. There was a lso n o difference 
in t h e density of ATPase-posit ive cells in abdominal wall skin 
when comparing C57Bl/6 mice with BALB/c mice (data not 
shown) . Thus, d iffere nces in Langerhans cell density (as d e te r-
mined by ATPase staining) do not appear to be a factor in 
determining wheth er sensitization or tolerance results from t h e 
application of an a llergic contactant to the tails of mice. 
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Twenty-two symptomatic primary Sjogren's syn-
drome patients with clinical and histologic evidence of 
skin disease were studied. Purpura and urticaria were 
the most frequent clinical cutaneou s manifestations. 
Most of these lesions were associated with a leukocyto-
clastic angiitis and, less comonly, a mononuclear (lym-
phocytic) vasculitis. Two main cutaneou s syndrom es 
were identified whose clinical, serologic, a nd histopath-
ologic features were indistinguish able from Walden-
strom's benign hyperglobulinemic purpura and hypo-
complementemic urticaria-like vasculitis. Eighty-four 
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nDNA: native deoxyribonucleic acid 
nRNP: nuclea1· ribonuclea1· protein 
SLE: systemic lupus erythematosus 
SS: Sjogren 's syndrome 
percent of primary Sjogren's syndrome patients with 
vasculitis demonstrated-' anti-Ro(SSA) antibodies. Thus, 
purpura and urticaria may reflect cutaneous vasculitis 
occurring in the clinical setting of Sjogren's syndrome. 
Although cuta neous vasculi t is is a well-recognized feature of 
Sjogren's syndrome (SS) [1] , its characteristics have not been 
well delineated. In the NIH studies of SS by B loch et a!, 33 of 
62 total patients had skin biopsies a nd 8 of these (24%) had 
vasculi t is, th e features of which were not elu cidated [2]. 
Recently, in a group of patien ts with SS we have reported a 
striking association between t h e presence of an tibodies to th e 
small ribonucleoprotein a ntigen, Ro(SSA) , and cer tain extra-
gla ndula r features [3, 4] including purpura, lympha denopathy, 
vasculitis, hematologic abnormali t ies (anemia, leukopenia, and 
thrombocytopenia ), and serologic hyperreactivity (hyperglob-
ulinemia, r h eumatoid a nd a ntinuclear factors, a nd cryoglobuli-
nemia) . We have observed biopsy-documented cutaneous vas-
culitis in 20 (27%) of th ese 75 pa tients who had either primary 
SS (9) or SS associated with a nother connective tissu e disorder, 
(systemic lupus eryt hematosus, 6; rhe umatoid arthri t is, 2; sys-
temic sclerosis, 2; or overlap syndrome, 1) [ 4]. 
Since cutaneous manifestations, including vasculi t is, are com-
mon fea tures of oth er connective tissue diseases, particulru·ly 
systemic lupus erythematosus and scleroderma, in t he present 
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study we have examined the clinical and histologic featmes of 
22 patients with prima1·y SS with skin lesions- 9 patients whose 
general features were described in the initial series [4] and 13 
additional patients. 
Palpable purpura and urticaria were the most common cu-
taneous lesions. Vasculitis was documented in 19 (86%) and the 
histopathology included leukocytoclastic angiitis and promi-
nent mononucleal' peTivascular infiltrates with, in some cases, 
frank invasion/destruction of vessel walls, i.e., resembling t he 
predominantly mononuclear vasculi tis described by Soter et al 
(5). 
MATERIALS AND METHODS 
Patient Selection 
Twenty-two symptomatic primary SS patients [6,7] with abnormal 
Schirmer's test, keratoconjunctivitis sicca, or positive minor sa livary 
gland biopsy (with at least 1 focus containing a minimum of 50 lym-
phocytes per aggregate per 4-mm2 tissue, grade 3 [8]) and clinical and 
histo logic evidence of skin disease were studied. SS patients with an 
associated connective tissue disorder (rheumatoid arthri tis [9], systemic 
lupus erythematosus [10], scleroderma [11], or an ill -defined or overlap 
synru·ome) were excluded. 
Laboratory Studies 
Hyperglobulinemia was defined as a serum globu lin concentration of 
greater than 3.5 gm/dl and/or a gamma globu lin concentration greater 
than 1.7 gm/dl. Rheumatoid factor was determined by the latex fixation 
test and considered positive at a dilution of greater than 1:80. Antinu-
clear antibodies were detected by indirect immunofluorescence tech-
niques using mouse liver as a su bstrate [1 2], with a dilution equal to or 
greater than t: 20 considered positive. The tota l hemolytic complement 
(CH50) was determined by a modification of the method of Mayer [13] 
and was considered abnormal if less than 25 uni ts were detected. 
Antibodies to nuclear r ibonuclear protein (nRNP) , Sm, native deoxy-
ribonucleic acid (nDNA), Ro(SSA) , and La (SSB) were determined as 
described previously [14]. 
Skin Biopsies 
Trephine biopsy specimens measuring 4 mm2 were obtained from 
skin lesions following infiltration with 1% lidocaine without epinephrine. 
The tissue was submitted for routine pathology examination, i.e., fixed 
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in 10% buffered formalin solu tion, embedded in paraffin, cut in to 6-JLm-
thick sections, stained with hematoxylin-eosin, and examined with a 
ligh t microscope. 
In selected cases, another portion of the biopsy specimen was frozen 
immediately in liquid ni trogen and stored at -70°C until sectioned. 
Frozen tissue sections were stained employing direct immunofluores-
cence techniques using monospecific fluorescein isothiocyanate (FITC)-
conjugated rabbit antisera to human IgG, lgM, lgA, and C3 as described 
previously [15]. The specificity of the antisera was confu·med by im-
munoelectrophoresis and immunodiffusion. Tissues were examined 
with an American Optical fluorescence microscope (Fluorolume) . 
Classification of Vascular Pathology 
Leukocytoclastic vasculi tis or necrotizing angiitis was defined patho-
logically by the histologic criteria of infiltrations of neutrophils and 
mononuclear cells within and around postcapillary venules, arterioles, 
or small arteries. Leukocytoclasis (nuclear debris or dust), fibrino id 
necrosis, and extravasation of eryth1·ocytes were associated fea tures. 
A mononuclear vascu li tis was considered present when, in addition 
to prominent perivascular infil tration, there was fra nk invasion and/ or 
disruption of the vesse l wall integri ty by mononuclear cells (lympho-
cytes, monocytes, plasma cells). Polymorphonuclear leukocytes were 
absent or infrequent. The morphology of lesions so classified resembles 
the predominantly mononuclear vasculitis described by Soter et a l [5]. 
RESULTS 
Demographic Features 
The mean age of t he 22 patients was 41 years (range, 13-69). 
Nineteen patients were women; eighteen were whi te and four 
black. 
Cutaneous Manifestations 
The clinical features of the primary SS patients are outlined 
in Table I. The most common clinical presentation was purpura, 
which occurred in 10 (45%) patients. The purpma were usually 
palpable and involved primarily the lower extremities. The 
second most common skin manifestation was chronic mticru·ia, 
present in 7 (32%) patients. Four patients with purpura or 
urticaria, in addi tion, had other skin lesions which included 
petechiae (2), digital ulcers (2) , erythema muJtiforme (1), and 
telangiectasia (1). 
TABLE l. Cutaneous manifestations of prim.a.ry Sjogren's syndrom.e 
Predominant skin lesions 
Patient Age/ Sex/ Race 
no. Purpura Urticaria Other 
1 13 F w +" 
2 18 F w + 
3 22 F w + 
4 25 F B + 
5 28 F B + 
6 31 F w + 
7 33 F B + 
8 34 F w + 
9 34 F w + 
10 34 M w + 
11 37 F w + 
12 39 F w + 
13 44 F w + 
14 45 M w + 
15 46 F w + 
16 49 F w + 
17 51 M w +'" 
18 53 F B + 
19 60 F w + 
20 65 F w + 
21 68 F w +" 
22 69 F w + 
40.8 ± 3.3 19 F:3 M 10 W:4 B 10/22 (45%) 7/22 (32o/t ) 5/22 (23%) 
" Erythema nodosum . 
"Two patients (No. 11 and 22) had both leukocytoclastic angiitis and mononuclear vasculitis. 
<Erythema pers tans. 
d Erythema multifonne. 
Histopathology 
Cutaneous vas· Leukocytoclas- Mononuclear 
culi tis tic angiitis vasculitis 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+'' + + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+" + + 
19/ 22 (86%) 14/ 19 (74%) 7/ 19 (37%) 
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Of the 5 remaining patients, without either purpura or urti-
caria, 1 each had erythema multiforme, erythema perstans, 
erythema nodosum, erythematous macules, and purplish tender 
subcu taneous nodules. 
Association with Systemic Disease and Vasculitis 
Clinical evidence of systemic organ involvement was present 
in 11 patients. Central nervous system disease (focal neurologic 
defects, seizures, or aseptic meningoencephalitis) was present 
in 8 patients. Three patients had biopsy-documented severe 
interstitial pneumonitis with fibrosis, 2 had interstitial nephritis, 
and 1 had chronic active hepatitis. 
Three patients with cutaneous vasculitis also had biopsy-
documented peripheral (nerve/muscle) vasculitis. Two patients 
had systemic vasculitis, one of whom expil'ed secondal'y to 
spinal subarachnoid hemorrhage from rupture of the anterior 
spinal artery which was involved with necrotizing arterit is. 
Histopathology 
Cutaneous vasculi t is was present in the biopsied skin lesions 
of 19 (86%) of 22 SS patients. The spectrum of histopathologic 
findings in the patients wi th vasculitis is shown in T able I and 
illustrated in Figs 1 and 2. 
The papillal'y as well as the reticular dermis contained in-
flammatory infiltrates, some of which surrounded and invaded 
glands, appendages, and vessel walls (Fig 1A ). Although super-
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fi cial venules and capillaries were uniformly involved, small 
arteries/arterioles within the deeper dermis or panniculus were 
also affected commonly. 
Leukocytoclastic angiitis, the most prevalent histopathologic 
finding, was present in 14 (74%) of the 19 patients with vasculitis 
(Figs IB,C, 2A ). Necrotizing panniculitis was demonstrated in 
2 of these patients (Fig. 2D). 
A prominent mononuclear perivascular infiltrate was seen in 
10 patients. Seven (37%) of the 19 patients with vascular ab-
normalit ies had mononuclear vasculitis with frank invasion and 
often destruction of the vessel wall with mononuclear cells 
(predominantly lymphocytes and occasionally plasma cells) 
(Figs 1D, 2B,C ). Veins, as well as smaJI arteries/arterioles, were 
involved in both histopathologic prototypes (i.e., leukocytoclas-
tic vasculitis and mononuclear vasculitis). 
Two patients had both leukocytoclastic angiitis and mono-
nuclear vasculitis. One of these patients, in addition, had acu te 
severe necrotizing arteritis of m edium-sized vessels with seg-
men tal transmural lesions and fibrinoid necrosis resembling 
polyarteritis nodosa. 
Clinical Correlation with Histopathologic Features 
The histopathologic correlates of the most common clinical 
cutaneous lesions are summarized in T able II. In eight (80%) of 
FIG 1. A, Skin biopsy from a patient (No. 21) with cutaneous vasculit is. Papillary and reticular derm is are inftltrated by inflammatory cells 
which sunound, and in some cases invade, vessel walls. X 60. B and C, Leukocytoclastic angii tis (mild and mo.re severe) in patients (Nos. 6 and 
1.1) with lower-extremity palpable purpura and hyperglobulinemia. B, x 340; C, x 325. D, Mononuclear (lymphocytic) vasculitis in a patient (No. 
22) with lower extremity palpable purpura and hyperglobulinemia. x 425. 
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F rG 2. A , Leukocytoclastic angi it is in a patient (No. 16) wit h chronic urticaria and hypocomplementemia . X 650. B, Mononuclear (lymphocytic) 
vasculitis in a patient (No. 15) with chronic urticaria a nd normocomplementemia. X 600. C, Mononuclear (lymphocytic) infiltrates, pet~vascular 
c uffing, and vasculi t is in a patient (No. 17) with e rythema perstans. X 11 5. D, N ecrotizing panniculitis a nd ar teritis in a pa tien t (No. 1) with 
erythe ma nodosum. X 300. 
TABLE II. Prim.wy Sjogren's syndrome: cutaneous m.a.ni(estation.s/ 
hist.opa.thologic correlates 
Cli nical features (no. of pa tients) 
Histopathology 
Other Purpura Urtica ri11 
Leukocytoclastic a ngiitis 6 5 1 
Mononuclear vascu li t is 2 1 2 
B oth leukocytoclastic a ngiitis 2 0 0 
a nd mononuclear vasculitis 
Perivascular c uffi ng only 0 2 
T otal patients 10 7 5 
10 patients, purpura was associated with leukocytociastic an-
giitis (Fig lB,C). Mononuclear (lymphocytic) vasculitis, how-
ever, was seen in 4 cases (40%) (Fig lD), 2 of whom also had 
le ukocytoclastic angiitis. 
Urticaria-like skin lesions were also usually associated with 
leukocytoclastic angiitis (Fig 2A ), which was present in 5 (71 %) 
of 7 cases. Mononuclear vasculitis was seen in one such case 
(14%) (Fig 2B) and the other failed to show vasculi tis. 
Other less frequent skin lesions also demonstrated these two 
main prototypes of histopathology. Erythema multiforme in 
one patient was associated with leukocytoclastic a ngiitis and in 
another with mononuclear vasculitis. Erythema perstans was 
associated with mononuclear vasculitis (Fig 2C) in a n additional 
patient. One of two patients with necrotizing panniculitis and 
leukocytoclastic angiitis had erythema nodosum-like lesions. 
Immunofluorescence 
Direct immunofluorescence was performed on the biopsies of 
involved skin in 12 cases. D eposition of immunoglobulin IgG 
(2) , IgM (2), IgA (1), and/ or C3 (3) within and around vessel 
walls was demonstrated in a total of 4 (33%) cases (Fig 3). Three 
of these patients with vascular deposition of immunoglobulin 
and/ or complement had leukocytoclastic angiitis and hypocom-
plementemia; while the fourth, with mononuclear vasculitis, 
was normocomplementemic. 
Serologic Associations 
Hyperglobulinemia with a polyclonal gammopathy was doc-
umented in 12 (59%) patients. Most commonly there was an 
increase in the serum concentration of all classes of immuno-
globulin, although in a few cases only IgG concentration was 
elevated. 
Hypocomplementemia was present in 8 patients, all of whom 
had leukocytoclastic angiitis (6 wi th leukocytoclastic vasculi tis 
alone and 2 with mononuclear vasculitis in addition) (Table 
III). In contrast, of the 5 patients with mononuclear vasculi ti 
a lone, all had normal serum complement levels. 
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FIG 3. Direct immunofluorescence of skin from a patient (No. 16) 
with hypocomplementemic urticaria-like vasculitis demonstrating dep-
osition of lgG within a blood vessel wall. x 400. 
TABLE III. Correlation of histopathology with serum complement 
levels in Sjogren's syndrome patients with cutaneo u.s vasculitis 
Serum complement (CH00) 
Low (<25 units) 
Normal (26-40 units) 
Total 
Leukocyto-
clastic angi- Both" 
itis 
2 
0 
2 
Mononu ~ 
clear vas- No. of pa-
culitis tients 
0 
5 
5 
8 
11 
19 
"Two patients had both leukocytoclastic angiitis and mononuclear 
vasculitis. 
b Five of these 6 SS patients had hypocomplementemic urticarial 
vasculitis (see text). 
Of 19 patients with cutaneous vasculitis, 16 (84%) had anti-
nuclear antibodies; while 14 (74%), in addition, had ~heumatoid 
factor. Antibodies to nDNA, Sm, or nRNP were not detected. 
Only 1 patient in this series, with long-standing SS and palpable 
pmpma, developed cryoglobulinemia. 
Sixteen (84%) patients had antibodies to Ro(SSA), while 9 
(47%), in addition, had antibodies to La(SSB). All 16 patients 
with vasculitis had anti-Ro(SSA) antibodies (9 of whom also 
had anti-LA(SSB) antibodies), while the 3 patients without 
vasculitis were seronegative (p < 0.0005). 
Waldenstr(jm 's Benign Hyperglobulinemic Purpura 
Eight (80%) of the individuals with purpura had hyperglob-
ulinemia. Six patients with lower-extremity palpable purpma, 
hyperglobulinemia, and a polyclonal gammapathy were indis-
tinguishable from Waldenstrom's benign hyperglobulinemic 
purpura [16,17]. In the other 2, with long-standing primary SS 
and lower-extremity palpable pmpma, SS was complicated by 
the late emergence of cryoglobulinemia, and disseminated vas-
culitis, in one case, and lymphoma, in the other. Of the 6 
patients with the clinical syndrome of Waldenstrom's benign 
hyperglobulinemic purpura, 4 had leukocytoclastic vasculitis 
alone, 1 mononuclear vasculitis, and 1 both leukocytoclastic 
vasculitis and mononuclear vasculitis. None was hypocomple-
mentemic. 
Hypocomplementemic Urtil!arial Vasculitis 
Five of 7 (71%) patients with urticaria and leukocytoclastic 
angiitis had hypocomplementemia, and thus by definition had 
hypocomplementemic urticaria-like vasculitis [18,19) (Table 
III). Two ofthese patients also had severe restrictive pulmonary 
disease with interstitial pneumonitis and fibrosis. 
DISCUSSION 
In a series of 22 primary SS patients with clinical and histo-
logic evidence of cutaneous involvement, purpura .and urticaria 
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were the most frequent cutaneous manifestations and were a 
reflection of vasculitis. 
Leukocytoclastic angiitis was the most common histopatho-
logic correlate and was seen in both purpmic and urticarial skin 
lesions. A mononuclear (predominantly lymphocytic) vasculitis, 
however, was present in a significant proportion of patients and, 
likewise, was seen in association with both types of skin lesions. 
It was not possible to clinically distinguish between either the 
purpura or urticaria-like lesions occurring in patients histolog-
ically demonstrating a necrotizing leukocytoclastic angiitis from 
patients possessing a mononuclear vasculitis. Furthermore, 
these two histologic lesions were found to coexist in 2 patients. 
Previous investigators describing the histopathologic spec-
trum of cutaneous vasculitis [5] have observed that, whereas 
mononuclear cells (lymphocytes) were the predominant cell 
type in the vascular infiltrates of some patients, small numbers 
of polymorphonuclear leukocytes also coexisted. In contrast, in 
several of our patients, mononuclear cells were present exclu-
sively in the vascular lesions. Furthermore, in addition to the 
involvement of postcapillary venules described by others [5], 
we have seen arte1·ioles and small arteries affected. 
Two clinical subsets of cutaneous vasculitis in SS were ob-
served in this study and resemble two well-described cutaneous 
disorders: Waldenstrom's benign hyperglobulinemic purpura 
and hypocomplementemic urticarial vasculitis. In 1943, Wal-
denstrom, in a study of hyperglobulinemia, described 3 women 
with unexplained recurrent purpura that he termed "benign 
purpura hyperglobulinemia" [16]. The patients had lower-ex-
tremity palpable purpma, elevated erythrocyte sedimentation 
rates, hyperglobulinemia, and leukopenia. Generalized lymph-
adenopathy, parotid swelling, and conjunctivitis were associ-
ated features. Waldenstrom subsequently reported SS patients 
with the typical clinical and laboratory features of pmpuric 
hyperglobulinemia [20). The coexistence of SS and Walden-
strom's benign hyperglobulinemic purpura subsequently has 
been reported by several authors [6,17,21]. In fact, it has been 
estimated that 20-30% of patients with Waldenstrom's benign 
hyperglobulinemic purpura have or will develop SS [22]. 
A second subset of SS patients in this study had clinical 
features, serum complement levels, and histopathology consist-
ent with the diagnosis of hypocomplementemic urticaria-like 
vasculitis [18,19]. Similar lesions have been described recently 
in systemic lupus erythematosus (SLE) [23], as have the ery-
thema multiforme lesions also seen in 2 of our patients [23]. As 
in the SLE patients, several of our SS patients demonstrated 
deposition of immunoglo_bulin and complement within vessel 
walls. 
Soter et al [5], have described two distinct cellular patterns 
of cutaneous necrotizing angiitis which correlated with differ-
ences in serum complement levels. In those individuals with 
hypocomplementemia, there was a preponderance of neutro-
phils within and surrounding the venules. In those patients with 
normocomplementemia, however, lymphocytes were more 
prominent in these locations. 
Of particular interest were 4 individuals within Soter's series 
of 16 patients [5] who had SS and palpable purpura. Three of 
these SS patients, with cryoglobulinemia and hypocomplemen-
temia, had a prominent neutrophil vascular infiltrate, while the 
fourth patient, with normal serum complement levels, had a 
predominantly mononuclear vascular infiltrate. In the present 
study, all 8 patients with hypocomplementemia demonstrated 
histopathologic evidence of leukocytoclastic angiitis. Mononu-
r.lear vasculitis alone, on the other hand, was present only in 
normocomplementemic individuals. 
The association of hypocomplementemia with urticaria-like 
vasculitis is consistent with tissue damage induced by immune 
complexes (Arthus reaction). The proposed pathogenesis of the 
mononuclear vasculitis, which is not associated with hypocom-
plementemia either in this series or that of Soter et al [5], is 
less clear. The mononuclear perivascular and vessel wall infil-
trates may represent a late or chronic phase of a classic immune 
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complex-mediated vasculitis. Soter (personal communication ) 
and we (unpublish ed o bser vations ), however , have performed 
serial biopsies of such lesions in individual patien ts and h ave 
not observed a tr a nsition from a Jeukocytoclastic a ngiitis to a 
mononuclear vasculit is. 
M ononuclear cells {lymphocytes), h owever, m ay play a pri -
m ary r ole in t h e genesis of the vasculitis and m ay m ediate 
vascular damage by a ny one or m ore of a variety of m echa nisms 
including deposit ion of immune complexes which do not fix 
complem en t, lymphocytotoxicity, or by production of lym pho-
kines or m ediators (which may be da m aging to t h e vessel wall, 
but do not attract poly morphonuclear leukocytes). 
I n reviewing the histopathology of vasculit is in SS, we h ave 
been impressed that th e lymphocytic com ponen t can be a 
prominen t feature of t he vasculit ic lesions not only in skin, but 
also in other organs (nerve, muscle, a nd viscera) [24,25]. Al-
t h o ugh th e concep t of m ononuclear or lymphocytic vasculitis is 
not a well-recognized enti ty, a number of other investigators 
studying vasculitis ha ve noted the presence of a prominent 
mononuclear {lym ph ocytic) com ponen t in som e cases [5,23,26J 
and have proposed a potentia! primary role of lymphocytes in 
t h e pathogenesis of vasculitis [26]. 
In SS, Kal treider and T ala! [27] have observed purpura in 6 
and a n urticarial skin lesion in 1 of 10 SS patien ts with periph-
eral neuropath y. Although only 2 cutaneous biopsies were 
perform ed (1 pmpuric lesion showed leukocytoclastic vasculi t is 
and t h e ur ticarial lesion ha d eosinophilic leukocytes aggregated 
a b ou t minute vessels), 3 muscle biopsies showed m ononuclear 
va sculit is . In p atien ts with lymphoproliferative di orders, si.Jn-
ilar blood vessel wall invasion by a bnormal lymphocytes has 
been termed lymphom atoid vasculi t is [26]. 
An association between cu taneous vasculitis and th e presence 
of anti-Ro (SSA) /La(SSB) an tibodies was documen ted in t his 
study . Ant ibodies to these small M ,. ribonucleoproteins are 
highly specific for connective tissue disorders (CTD) , occmring 
in less tha n 0.1% of h ospitalized patien ts wi thou t known CTD 
(3]. Whereas formerly t hese a u toantibodies were considered 
specific and sensit ive m arkers for primar y SS, r ecently, an t i-
bodies to R o (SSA) have been observed in 40-50% of patien ts 
with SS (alone or in association with a noth er CTD) , in a pprox-
imately 25% of S LE patien ts [14], a nd in several inter esting 
sub sets of CTD including subacute cutaneous lupus ery them a-
tosus, neonatal lupus syndrom e, a nd homozygous C2 deficiency 
associated with a lup us-like syndrome [3]. Fur thermore, a r e-
cent study of SS has demonstrated a striking correlation be-
tween a n t ibodies to Ro(SSA) a nd vasculitis (both peripheral 
and visceral) , [3] which has been confir m ed in t his s tudy of 
cu tan eous vasculi t is. 
T hus, a ntibodies to the R o (SSA) a nd La (SSB) a n tigen sys-
tem s may serve as useful serologic m arkers for t he presence of 
CTD, such as SS, in patien ts with certa in cutaneous m a nifes-
tations, particularly of the pur puric a nd urt icarial types. Al-
though in this study all of our patients wi th SS were sympto-
matic for the sicca complex, the presence of these a nt ibodies 
should provide the il11petus to rigorously evaluate a patien t for 
t h e sicca complex including a m inor saliva1·y gla nd biopsy. 
Conversely, in pa tients with unexplained cu taneous lesions 
(particularly pmpura and urticaria on a vasculi t is basis), th e 
diagnosis of SS should be enter tained and the appropria te 
diagnostic and serologic s tudies performed . 
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